Sort by
Refine Your Search
-
Program
-
Field
-
from this research inform the development of new diagnostics, treatments, and vaccines against malaria, tuberculosis, schistosomiasis, Chagas and other neglected tropical diseases. Are you excited by
-
disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees, the Department of Biomedicine is the largest
-
develop new therapies for vision loss. It is a place where your expertise will be valued, your abilities challenged, and your knowledge expanded. We are seeking qualified and highly motivated Research
-
, developing novel and innovative independent lines of research and significantly contributing to the lab's scientific vision.
-
We offer you The Department of Biomedicine is an equal opportunity employer and a cutting-edge research facility that provides excellent training and career development opportunities for his
-
" (D2M). This innovative project is a collaboration between the University of Basel, the Bern University of the Arts, and the FHNW. The goal is to develop a highly automated, reproducible pipeline
-
) investigates the biology and transmission of pathogens. Findings from this research inform the development of new diagnostics, treatments, and vaccines against malaria, tuberculosis, schistosomiasis, Chagas and
-
detachment, will make myopia the leading cause of blindness worldwide. Our team aims to understand the cellular and molecular mechanisms of myopia and to develop new therapies that can halt or reverse myopia
-
human tissues. These gaps hinder the development of physiologically relevant laboratory models for drug discovery. As part of the Swiss research network http://www.nccr-antiresist.ch/ , the Bumann lab
-
of tropical and synthetic rubber and other industrial materials, the project explores the transformative practices that industrial research & development brought to the twentieth-century marketplace and the